The document is a Quarterly Activities and Appendix 4C Cash Flow Report from Opthea Limited for the period ending 31 March 2026. It outlines financial activities including a net cash usage of AUD 1.47 million in operating activities and no significant investing activities. The company had a cash balance of AUD 31.203 million at the end of the quarter. Major expenses included research and development and administration costs. Financing activities saw a net cash outflow of AUD 30.519 million. The report also briefly discusses the company's strategy for reinstating its securities on the ASX and includes forward-looking financial statements.
Key Points
Opthea Limited released its Quarterly Activities/Appendix 4C Cash Flow Report for the period ending 31 March 2026.
The report details cash flows from operating activities, investing activities, and financing activities.
Net cash used in operating activities was AUD 1.47 million for the quarter.
Research and development expenses amounted to AUD 0.2 million, while administration costs were AUD 1.1 million.
The company had cash and cash equivalents of AUD 31.203 million at the end of the quarter.
Opthea did not engage in any significant investing activities during the quarter.
The company reported net cash used in financing activities of AUD 30.519 million, primarily due to borrowings.
The report mentions future operating activity cash availability and funding estimates.
Opthea plans to seek reinstatement of its securities on the ASX in the first half of the calendar year 2026.
The report includes forward-looking statements about Opthea's financial performance and operational projections.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.